(Q42547586)

2 November 2017

Enhancement of radiation-induced regrowth delay by gemcitabine in a human tumor xenograft model (English)

1 reference

2 November 2017

1 reference

1 reference

M A Joschko

1

1 reference

2 November 2017

L K Webster

2

1 reference

2 November 2017

J Groves

3

1 reference

2 November 2017

K Yuen

4

1 reference

2 November 2017

M Palatsides

5

1 reference

2 November 2017

D L Ball

6

1 reference

2 November 2017

M J Millward

7

1 reference

2 November 2017

1 January 1997

1 reference

Radiation Oncology Investigations

2 November 2017

1 reference

2 November 2017

5

1 reference

2 November 2017

2

1 reference

2 November 2017

62-71

1 reference

2',2'-Difluoro-deoxycytidine (gemcitabine) incorporation into RNA and DNA of tumour cell lines

2 November 2017

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281997%295%3A2%3C62%3A%3AAID-ROI4%3E3.0.CO%3B2-H

Advanced breast cancer: a phase II trial with gemcitabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281997%295%3A2%3C62%3A%3AAID-ROI4%3E3.0.CO%3B2-H

A phase II study of Gemcitabine (LY 188011) in patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281997%295%3A2%3C62%3A%3AAID-ROI4%3E3.0.CO%3B2-H

5-Fluorouracil radiation sensitization--a brief review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281997%295%3A2%3C62%3A%3AAID-ROI4%3E3.0.CO%3B2-H

Comparison of the induction of apoptosis in human leukemic cell lines by 2',2'-difluorodeoxycytidine (gemcitabine) and cytosine arabinoside

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281997%295%3A2%3C62%3A%3AAID-ROI4%3E3.0.CO%3B2-H

The influence of the schedule and the dose of gemcitabine on the anti-tumour efficacy in experimental human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281997%295%3A2%3C62%3A%3AAID-ROI4%3E3.0.CO%3B2-H

The potentiation of radiation response on murine tumor by fludarabine phosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281997%295%3A2%3C62%3A%3AAID-ROI4%3E3.0.CO%3B2-H

Gemcitabine: current status of phase I and II trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281997%295%3A2%3C62%3A%3AAID-ROI4%3E3.0.CO%3B2-H

Phase II study of gemcitabine (2',2'-difluorodeoxycytidine) given as a twice weekly schedule to previously untreated patients with non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281997%295%3A2%3C62%3A%3AAID-ROI4%3E3.0.CO%3B2-H

Kinetics of cisplatin-induced apoptosis in murine mammary and ovarian adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281997%295%3A2%3C62%3A%3AAID-ROI4%3E3.0.CO%3B2-H

Kinetics of mitotic arrest and apoptosis in murine mammary and ovarian tumors treated with taxol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281997%295%3A2%3C62%3A%3AAID-ROI4%3E3.0.CO%3B2-H

Apoptosis in Irradiated Murine Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281997%295%3A2%3C62%3A%3AAID-ROI4%3E3.0.CO%3B2-H

Schedule-dependent therapeutic gain from the combination of fractionated irradiation plus c-DDP and 5-FU or plus c-DDP and cyclophosphamide in C3H/Km mouse model systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281997%295%3A2%3C62%3A%3AAID-ROI4%3E3.0.CO%3B2-H

Antitumor activity of prolonged as compared with bolus administration of 2',2'-difluorodeoxycytidine in vivo against murine colon tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281997%295%3A2%3C62%3A%3AAID-ROI4%3E3.0.CO%3B2-H

10.1002/(SICI)1520-6823(1997)5:2<62::AID-ROI4>3.0.CO;2-H

21 January 2018

Identifiers

DOI

1 reference

2 November 2017

1 reference